VIDEO: Apalutamide’s tolerability in prostate cancer patients
19 May 2025
byDr. Darren Poon, Specialist in Clinical Oncology , Hong Kong Sanatorium & Hospital, Chinese University of Hong Kong , Hong Kong
Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, discusses apalutamide’s tolerability in prostate cancer patients.
